Apellis Pharmaceuticals, Inc. (APLS)
22.02
+1.07
(+5.11%)
USD |
NASDAQ |
Jan 22, 16:00
22.05
+0.03
(+0.14%)
After-Hours: 20:00
Apellis Pharmaceuticals Free Cash Flow: 78.64M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics, Inc. | 9.691M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Ionis Pharmaceuticals, Inc. | -309.48M |
| Fortress Biotech, Inc. | -30.14M |
| Sarepta Therapeutics, Inc. | -401.63M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 108.47M |
| Cash from Investing (Quarterly) | -0.148M |
| Cash from Financing (Quarterly) | 0.793M |
| Free Cash Flow Per Share (Quarterly) | 0.8328 |
| Free Cash Flow to Equity (Quarterly) | 102.71M |
| Free Cash Flow to Firm (Quarterly) | 119.57M |
| Free Cash Flow Yield | 2.82% |